# US 2013/0253176 A1 · Host cells comprising alpha 1, 2 mannosidase and culture methods thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2013/0253176 A1
- Document ID: US20130253176A1
- Status: Published application
- Kind: A1
- Application number: 13/905,466
- Filed: 2013-05-30
- Published: 2013-09-26
- Earliest claimed: 2005-12-08
- Assignees: Amgen Inc.
- Applicants: Amgen Inc.
- Inventors: Christopher Kenyon Crowell
- Web page: https://patentgrep.com/patent/US20130253176A1

## CPC

- C12P 21/005: {Glycopeptides, glycoproteins}
- C07K 14/505: Erythropoietin [EPO]
- C12N 5/0693: {Tumour cells; Cancer cells}
- C12N 9/2402: {hydrolysing O- and S- glycosyl compounds (3.2.1)}
- C12N 15/85: for animal cells
- C12Q 1/6809: Methods for determination or identification of nucleic acids involving differential detection
- C12Y 302/01024: Alpha-mannosidase (3.2.1.24)
- G01N 33/746: {Erythropoetin}
- C12N 2500/95: Protein-free medium and culture conditions
- C12N 2501/999: Small molecules not provided for elsewhere
- C12N 2510/02: Cells for production
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Y: ENZYMES
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

Improved host cells and culture methods involving overexpression of MAN1C1 activity to improve protein production are provided.

## Claims

### Claim at position 1

1-23. (canceled)

### Claim 24

A glycoprotein product produced by a process comprising the steps of:
culturing an isolated host cell engineered to overexpress (a) alpha 1,2 mannosidase (MAN1C1) native to the host cell and (b) a glycoprotein of interest, wherein the MAN1C1 polypeptide is expressed at a level that increases specific productivity (pg/cell/day) of said glycoprotein of interest compared to an unaltered host cell in culture medium; and recovering the glycoprotein of interest from the host cell or culture medium.

### Claim 25 (depends on 24)

The glycoprotein product produced by the process of claim 24 wherein said host cell is cultured under conditions that induce increased MAN1C1 expression.

### Claim 26 (depends on 24)

The glycoprotein product produced by the process of claim 24 wherein said host cell expresses MAN1C1 protein at a level that increases specific productivity (pg/cell/day) of glycoprotein of interest produced.

### Claim 27 (depends on 26)

The glycoprotein product produced by the process of claim 26 wherein at least a 2-fold increase in specific productivity is achieved by overexpression of MAN1C1.

### Claim 28 (depends on 24)

The glycoprotein product produced by the process of claim 24 wherein said host cell has been transfected with a vector comprising a nucleic acid encoding MAN1C1 operably linked to a heterologous expression control sequence.

### Claim 29 (depends on 24)

The glycoprotein product produced by the process of claim 24 wherein said host cell comprises a heterologous expression control sequence operably linked to a nucleic acid encoding MAN1C1.

### Claim 30 (depends on 24)

The glycoprotein product produced by the process of claim 24 wherein said host cell has been transfected with a vector comprising a nucleic acid encoding said glycoprotein of interest operably linked to a heterologous expression control sequence.

### Claim 31 (depends on 24)

The glycoprotein product produced by the process of claim 24 wherein said host cell comprises a heterologous expression control sequence operably linked to a nucleic acid encoding said glycoprotein of interest.

### Claim 32 (depends on 24)

The glycoprotein product produced by the process of claim 24 wherein the glycoprotein of interest is an erythropoiesis-stimulating molecule.

### Claim 33 (depends on 24)

The glycoprotein product produced by the process of claim 24 wherein the glycoprotein of interest is erythropoietin of SEQ ID NO: 3.

### Claim 34 (depends on 24)

The glycoprotein product produced by the process of claim 24 wherein the glycoprotein of interest is darbepoetin of SEQ ID NO: 5.

### Claim 35 (depends on 24)

The glycoprotein product produced by the process of claim 24 wherein the host cell is a mammalian cell.

### Claim 36 (depends on 24)

The glycoprotein product produced by the process of claim 24 wherein the host cell is a CHO cell.

### Claim 37 (depends on 24)

The glycoprotein product produced by the process of claim 24 wherein the host cell is a human cell.

### Claim 38 (depends on 24)

The glycoprotein product produced by the process of claim 24 wherein the host cell is a BHK cell.

### Claim 39 (depends on 24)

The glycoprotein product produced by the process of claim 24 wherein the host cell is an NS/0 cell.

### Claim 40 (depends on 24)

The glycoprotein product produced by the process of claim 24 wherein the host cell is an HT-1080 cell.
